Janux Therapeutics, Inc. (JANX)
14.93
+0.40
(+2.75%)
USD |
NASDAQ |
Apr 10, 16:00
15.24
+0.31
(+2.08%)
After-Hours: 20:00
Janux Therapeutics Enterprise Value : -36.21M for April 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Bristol Myers Squibb Co. | 155.88B |
| EyePoint Plc | 900.61M |
| CorMedix, Inc. | 572.05M |
| ADMA Biologics, Inc. | 2.302B |
| Viking Therapeutics, Inc. | 3.253B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.95M |
| Total Expenses (Quarterly) | 31.95M |
| EPS Diluted (Quarterly) | -0.514 |
| Earnings Yield | -12.28% |
| Normalized Earnings Yield | -12.28 |